TrialInternational journal of hematology2025

Intravenous umbilical cord-derived mesenchymal stromal cell therapy may improve overall survival in Japanese patients with idiopathic pneumonia syndrome after hematopoietic stem cell transplantation: a multicenter, single-arm, phase II trial.

Noriko Doki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.